Delivery Order SPE2DB22D2211-SPE2DB25FSCJW
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,839.68 for Zonisade 100 mg/5 ml oral suspension (150 ml) on June 17, 2025, with completion scheduled for June 18, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract structure and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,097.28 by the Defense Logistics Agency on September 8, 2025, for the supply of Zonisade 100 mg/5 mL oral suspension in a 150 mL container. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zonisade 100 mg/5 ml oral suspension, a pharmaceutical product, with a ceiling value of $1,546.43. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The contract was awarded on April 14, 2025, and was not set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zonisade 100 mg/5 ml oral suspension, a pharmaceutical product. The contract has a firm fixed price of $12,926.55 and a period of performance through April 22, 2025. This contract is not set-aside and was awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML. The contract has a ceiling value of $4,770.65 and a period of performance through November 30, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle...
- The federal contract award summarized here is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA). The contract, valued at $4,354.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 15, 2023. The contract is not designated with any...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $672 delivery order to Amerisourcebergen Drug Corporation for 4562180755 ZONISADE 100 MG/5 ML ORAL SUSP 150ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for the delivery of pharmaceutical products to a Defense Logistics Agency location in Conshohocken, Pennsylvania. Performance will take place from September 14 to 15, 2023. No subcontractors or set aside designations were identified. The...